Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 92922

1 recalled-product record grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
August 23, 2023
Product types
Drug
Classifications
Class III
Statuses
Terminated
Recalling firm wording
Contract Pharmaceuticals Limited Canada

Dossier provenance

Source snapshots represented here

  • openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

1 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 1

Clindamycin Phosphate Topical Solution USP, 1%, 60 mL bottle, Rx only, Manufactured by: Contract Pharmaceuticals Limited Canada, Mississauga, Ontario, Canada, Manufactured for: Glasshouse Pharmaceuticals Limited Canada, Mississauga, Ontario, Canada, NDC# 71428-003-60

D-1139-2023
Recall number
D-1139-2023
Initiated
August 23, 2023
Classification
Class III
Status
Terminated
Quantity
11,350 bottles

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Defective Container: slow leakage under the cap

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Defective Container: slow leakage under the cap

Code information

Lot # 118920, exp. January 2024.

Distribution pattern

Nationwide in the USA.